1020536-15-5

Basic information

• Product Name: N-(3-((6-acetamidopyridin-3-yl)ethynyl)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide
• Synonyms: N-(3-((6-acetamidopyridin-3-yl)ethynyl)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide
• CAS NO: 1020536-15-5
• Molecular Weight: 439.473
• Mol File: 1020536-15-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-((6-acetamidopyridin-3-yl)ethynyl)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-((6-acetamidopyridin-3-yl)ethynyl)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide(1020536-15-5)
• EPA Substance Registry System: N-(3-((6-acetamidopyridin-3-yl)ethynyl)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide(1020536-15-5)

Safety Data

• Hazardous Substances Data: 1020536-15-5(Hazardous Substances Data)

Upstream product

• 7169-97-3 N-(5-bromopyridin-2-yl)acetamide 
• 1020536-55-3 N-(3-ethynylphenyl)-2-oxo-3-phenylimidazolidine-1-carboxamide 

Relevant articles and documents

KINASE INHIBITORS AND USES THEREOF

The present invention relates to compounds of the general formula (A) and pharmaceutical compositions thereof that inhibit protein tyrosine activity. In particular the invention relates to said compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signalling, for example, the inhibition of VEGF receptor signalling and HGF receptor signalling. Said compounds and compositions are useful for the treatment of cell proliferative diseases and conditions.